Background to service. 2.1 The investment made by the NHS in medicines is for the explicit purpose of delivering health gain to the population. For this investment to bring the best possible outcomes for the people who are prescribed these medicines, pharmaceutical care of the correct quality has to be delivered reliably, safely, effectively and efficiently. The 2011 Regulations to the National Health Service (Pharmaceutical Services) (Scotland) Act Regulations 2009, places a duty on Boards to secure adequate pharmaceutical care services for the patients within their boundaries. Where medicines are prescribed by secondary care services, it may be appropriate for the specified pharmaceutical care to be provided by community pharmacy or homecare. The placement of community pharmacies and their integration within the local healthcare system may mean that they are the preferred route of service provision. 2.2 Pharmaceutical Care Services, provided by community pharmacy, for patients receiving medicines initiated by secondary care has a number of advantages over traditional homecare services: • Service provision is more likely to be fully integrated with other local services delivered within the local healthcare system. • Access by vulnerable populations is facilitated, including those with less stable lifestyles and the homeless. • Effective communication is promoted between community pharmacy, general practice and the secondary care service. • Ensuring that patients’ medicines are provided within the context of other medicines prescribed in primary care and the pharmaceutical care needs of the patient. • Supports the validity and reliability of the community pharmacy held pharmaceutical care record. • Enables assessment of patients’ needs for compliance support and delivery of enhanced support where required as part of the patients’ clinical management plan.
Appears in 2 contracts
Sources: Framework Service Level Agreement, Framework Service Level Agreement
Background to service. 2.1 The investment made by the NHS in medicines is for the explicit purpose of delivering health gain to the population. For this investment to bring the best possible outcomes for the people who are prescribed these medicines, pharmaceutical care of the correct quality has to be delivered reliably, safely, effectively and efficiently. The 2011 Regulations to the National Health Service (Pharmaceutical Services) (Scotland) Act Regulations 2009, places a duty on Boards to secure adequate pharmaceutical care services for the patients within their boundaries. Where medicines are prescribed by secondary care services, it may be appropriate for the specified pharmaceutical care to be provided by community pharmacy or homecare. The placement of community pharmacies and their integration within the local healthcare system may mean that they are the preferred route of service provision.
2.2 Pharmaceutical Care Services, provided by community pharmacy, for patients receiving medicines initiated by secondary care are has a number of advantages over traditional homecare services: • Service provision is more likely to be fully integrated with other local services delivered within the local healthcare system. • Access by vulnerable populations is facilitated, including those with less stable lifestyles and the homeless. • Effective communication is promoted between community pharmacy, general practice and the secondary care service. • Ensuring that patients’ medicines are provided within the context of other medicines prescribed in primary care and the pharmaceutical care needs of the patient. • Supports the validity and reliability of the community pharmacy held pharmaceutical care record. • Enables assessment of patients’ needs for compliance support and delivery of enhanced support where required as part of the patients’ clinical management plan.
Appears in 1 contract
Sources: Framework Service Level Agreement